Prof. Jens J. Holst speaks at the 8^th ICBAS/FF Conference Cycle!

Prof. Jens J. Holst, from the University of Copenhagen and collaborator of the Endocrine, Cardiovascular & Metabolic Research of UMIB, will be speaking at the 8th ICBAS/FF Conference.

His talk will be entitled "The liver-alpha cell axis in health and type 2 diabetes", and it will be held at the 13h o'clock of the 2^th October 2019, at the Amphiteathre 8 of ICBAS/FF.

Here you can find a short biography of Prof. Holst and the scheduled talks on the Conference Cycle, until December 2019.

We hope to see you there!

UMIB researcher was present at the 16th ICAPA!

Raquel Faria, MD at the Unit of Clinical Immunology (UIC) and member of the "Autoimmunity & Neurosciences" of UMIB, took two research works, as posters, to the 16th International Congress on Antiphospholipid Antibodies (ICAPA).

This conference, held in Manchester, United Kingdom, from 17th to 20th September 2019, gathered specialists in antiphospholipid syndrome from all over the world. In this edition, the new Classification Criteria, Treatment Recommendations, Experimental Model of the Disease and the Potential Treatment Options were discussed.

A researcher from UMIB attended the AVANCE/TopSpin Basic course!

David F. Carraget, MSc, PhD student and researcher of the Biology & Genetics of Reproduction research group of UMIB, has attended the AVANCE/TopSpin course - Autumn 2019, one of the courses on NMR organized by Bruker.

This edition was held at the Bruker BioSpin GmbH headquarters in Rheinstetten, Germany, from 16^th to 20^th September 2019. Congratulations!

UMIB researchers were present at the "ECTRIMS'19"!

A delegation of UMIB researchers from the Autoimmunity & Neurosciences research group was present at the ECTRIMS'19.

This conference was held in Stockholm, Sweden, from 11th to 13th September 2019, and was focused on the treatment and research in Multiple Sclerosis.

To get more acquainted about the scope of our researchers' participation in this congress, you can follow the interview granted by one of the researcher, Bárbara Guerra Leal, PhD, to NewsPharma [in Portuguese].